» Articles » PMID: 22037869

Phosphorylation of Carbonic Anhydrase IX Controls Its Ability to Mediate Extracellular Acidification in Hypoxic Tumors

Overview
Journal Cancer Res
Specialty Oncology
Date 2011 Nov 1
PMID 22037869
Citations 64
Authors
Affiliations
Soon will be listed here.
Abstract

In the hypoxic regions of a tumor, carbonic anhydrase IX (CA IX) is an important transmembrane component of the pH regulatory machinery that participates in bicarbonate transport. Because tumor pH has implications for growth, invasion, and therapy, determining the basis for the contributions of CA IX to the hypoxic tumor microenvironment could lead to new fundamental and practical insights. Here, we report that Thr443 phosphorylation at the intracellular domain of CA IX by protein kinase A (PKA) is critical for its activation in hypoxic cells, with the fullest activity of CA IX also requiring dephosphorylation of Ser448. PKA is activated by cAMP, which is elevated by hypoxia, and we found that attenuating PKA in cells disrupted CA IX-mediated extracellular acidification. Moreover, following hypoxia induction, CA IX colocalized with the sodium-bicarbonate cotransporter and other PKA substrates in the leading edge membranes of migrating tumor cells, in support of the concept that bicarbonate metabolism is spatially regulated at cell surface sites with high local ion transport and pH control. Using chimeric CA IX proteins containing heterologous catalytic domains derived from related CA enzymes, we showed that CA IX activity was modulated chiefly by the intracellular domain where Thr443 is located. Our findings indicate that CA IX is a pivotal mediator of the hypoxia-cAMP-PKA axis, which regulates pH in the hypoxic tumor microenvironment.

Citing Articles

Association between glycolysis markers and prognosis of liver cancer: a systematic review and meta-analysis.

Wang B, Pu R World J Surg Oncol. 2023; 21(1):390.

PMID: 38114977 PMC: 10731852. DOI: 10.1186/s12957-023-03275-4.


Selective Tumor Hypoxia Targeting Using M75 Antibody Conjugated Photothermally Active MoO Nanoparticles.

Annusova A, Labudova M, Truchan D, Hegedusova V, Svajdlenkova H, Micusik M ACS Omega. 2023; 8(47):44497-44513.

PMID: 38046334 PMC: 10688043. DOI: 10.1021/acsomega.3c01934.


Repurposing of World-Approved Drugs for Potential Inhibition against Human Carbonic Anhydrase I: A Computational Study.

Zheng N, Jiang W, Zhang P, Ma L, Chen J, Zhang H Int J Mol Sci. 2023; 24(16).

PMID: 37628799 PMC: 10454238. DOI: 10.3390/ijms241612619.


Propranolol, Promising Chemosensitizer and Candidate for the Combined Therapy through Disruption of Tumor Microenvironment Homeostasis by Decreasing the Level of Carbonic Anhydrase IX.

Puzderova B, Belvoncikova P, Grossmannova K, Csaderova L, Labudova M, Fecikova S Int J Mol Sci. 2023; 24(13).

PMID: 37446271 PMC: 10341831. DOI: 10.3390/ijms241311094.


A Carbonic Anhydrase IX/SLC1A5 Axis Regulates Glutamine Metabolism Dependent Ferroptosis in Hypoxic Tumor Cells.

Venkateswaran G, McDonald P, Chafe S, Brown W, Gerbec Z, Awrey S Mol Cancer Ther. 2023; 22(10):1228-1242.

PMID: 37348875 PMC: 10543979. DOI: 10.1158/1535-7163.MCT-23-0041.